BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33582374)

  • 1. Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia.
    Severiche-Bueno DF; Severiche-Bueno DF; Bastidas A; Caceres EL; Silva E; Lozada J; Gomez S; Vargas H; Viasus D; Reyes LF
    Int J Infect Dis; 2021 Apr; 105():32-39. PubMed ID: 33582374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
    Kozakova J; Krizova P; Maly M
    PLoS One; 2021; 16(2):e0247862. PubMed ID: 33635933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of
    Camacho Moreno G; Imbachi LF; Leal AL; Moreno VM; Patiño JA; Gutiérrez IF; Beltrán S; Álvarez-Olmos MI; Mariño C; Barrero R; Espinosa F; Ramos N; Castellar LP; Sánchez N; Montañez A
    Hum Vaccin Immunother; 2020 Sep; 16(9):2300-2306. PubMed ID: 32078398
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.
    Wei SH; Chiang CS; Chiu CH; Chou P; Lin TY
    Pediatr Infect Dis J; 2015 Mar; 34(3):e71-7. PubMed ID: 25247584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
    Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
    Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
    Tempia S; Wolter N; Cohen C; Walaza S; von Mollendorf C; Cohen AL; Moyes J; de Gouveia L; Nzenze S; Treurnicht F; Venter M; Groome MJ; Madhi SA; von Gottberg A
    BMC Infect Dis; 2015 Oct; 15():450. PubMed ID: 26496761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential impact of PCV-13, PCV-15 and PCV-20 vaccines in Colombia.
    Serrano-Mayorga CC; Ibáñez-Prada ED; Restrepo-Martínez JM; Garcia-Gallo E; Duque S; Severiche-Bueno DF; Severiche-Bueno DF; Gomez S; Vargas H; Reyes LF
    Vaccine; 2024 Mar; 42(7):1435-1439. PubMed ID: 38336559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.
    Marrie TJ; Tyrrell GJ; Majumdar SR; Eurich DT
    Vaccine; 2018 May; 36(21):2985-2990. PubMed ID: 29685595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
    Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
    Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
    Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
    Meiring S; Cohen C; Quan V; de Gouveia L; Feldman C; Karstaedt A; Klugman KP; Madhi SA; Rabie H; Sriruttan C; von Gottberg A;
    PLoS One; 2016; 11(2):e0149104. PubMed ID: 26863135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    De Wals P; Lefebvre B; Deceuninck G; Longtin J
    Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
    Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
    Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
    Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the changing pneumococcal national immunisation program among older Australians.
    Menzies R; Stein AN; Booy R; Van Buynder PG; Litt J; Cripps AW
    Vaccine; 2021 Jan; 39(4):720-728. PubMed ID: 33384189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
    Rinta-Kokko H; Palmu AA; Auranen K; Nuorti JP; Toropainen M; Siira L; Virtanen MJ; Nohynek H; Jokinen J
    Vaccine; 2018 Apr; 36(15):1934-1940. PubMed ID: 29526371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.